P. M. Mathisen

发表

Gene therapy for autoimmune demyelinating disease of the central nervous system.

V. Tuohy, P. M. Mathisen, 1999, Archivum immunologiae et therapiae experimentalis.

Th2 T cells expressing transgene PDGF-A serve as vectors for gene therapy in autoimmune demyelinating disease.

V. Tuohy, A. Nishiyama, J. M. Johnson, 1999, Journal of autoimmunity.

Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells

V. Tuohy, J. Drazba, Justin M. Johnson, 1997, The Journal of experimental medicine.

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

R. Rudick, R. Ransohoff, V. Tuohy, 1998, Neurology.

Stabilization of myelin mRNAs as measured in a brain slice system

J. M. Johnson, Justin M. Johnson, P. M. Mathisen, 1997, Journal of neuroscience research.

The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

R. Kinkel, V. Tuohy, Justin M. Johnson, 1998, Immunological reviews.

A comparison between haematological parameters in 'capillary' and venous blood from healthy adults.

L. Daae, S. Halvorsen, K. Mironska, 1988, Scandinavian journal of clinical and laboratory investigation.

Modulation of the IL-10/IL-12 cytokine circuit by interferon-β inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis

V. Tuohy, Justin M. Johnson, Min Yu, 2000, Journal of Neuroimmunology.

T cell design for therapy in autoimmune demyelinating disease

V. Tuohy, P. M. Mathisen, 2000, Journal of Neuroimmunology.

33 Gene therapy for autoimmune diseases

K. Tuohy, P. M. Mathisen, 2000 .

Gene therapy for autoimmune diseases

V. Tuohy, P. M. Mathisen, 2000 .

Visinin-like Protein (VILIP) Is a Neuron-specific Calcium-dependent Double-stranded RNA-binding Protein*

V. Tuohy, Justin M. Johnson, P. M. Mathisen, 1999, The Journal of Biological Chemistry.

Gene therapy in the treatment of autoimmune disease.

V. Tuohy, P. M. Mathisen, 1998, Immunology today.

Pre-Emptive Targeting of the Epitope Spreading Cascade with Genetically Modified Regulatory T Cells During Autoimmune Demyelinating Disease1

V. Tuohy, A. Edling, Justin M. Johnson, 2001, The Journal of Immunology.

Demyelinating Disease Regulatory T Cells During Autoimmune Modified Spreading Cascade with Genetically Pre-Emptive Targeting of the Epitope

V. Tuohy, A. Edling, Justin M. Johnson, 2001 .

Gene Therapy in Experimental Autoimmune Encephalomyelitis

V. Tuohy, P. M. Mathisen, 2000, Journal of Clinical Immunology.

Gene discovery and validation for neurodegenerative diseases.

Peter M Mathisen, P. M. Mathisen, 2003, Drug discovery today.

Differential DM20 mRNA expression distinguishes two distinct patterns of spontaneous recovery from murine autoimmune encephalomyelitis

V. Tuohy, Min Yu, P. M. Mathisen, 2001, Journal of neuroscience research.

T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification

V. Tuohy, P. M. Mathisen, 1998 .

Digitized image analysis reveals diffuse abnormalities in normal‐appearing white matter during acute experimental autoimmune encephalomyelitis

V. Tuohy, B. Fuss, J. Drazba, 1998 .

Digitized image analysis reveals diffuse abnormalities in normal-appearing white matter during acute experimental autoimmune encephalomyelitis.

V. Tuohy, B. Fuss, J. Drazba, 1998, Journal of neuroscience research.